Table 1.
Incidence of suspected clinically apparent brain injury before and during the peak of the COVID-19 pandemic in pediatric patients presenting with diabetic ketoacidosis.
| Time period | Test statistic | P value | ||
|---|---|---|---|---|
| Before pandemic | During pandemic | |||
| Total | ||||
| Number of episodes of DKA (n = 503) | 344 | 159 | ||
| Number of patients with suspected CABI (n = 36) | 18 | 18 | ||
| Incidence of suspected CABI (7.3%) | 5.2% | 11.3% | χ 2 = 6.066 | 0.014 |
| New diabetes diagnosis versus established diabetes | ||||
| New | ||||
| Number of episodes of DKA (n = 319) | 216 | 103 | ||
| Number of patients with suspected CABI (n = 30) | 15 | 15 | ||
| Incidence of suspected CABI (9.4%) | 6.9% | 14.6% | χ 2 = 4.751 | 0.029 |
| Established | ||||
| Number of episodes of DKA (n = 184) | 128 | 56 | ||
| Number of patients with suspected CABI (n = 6) | 3 | 3 | ||
| Incidence of suspected CABI (3.3%) | 2.3% | 5.4% | Fisher's exact test | 0.371 |
CABI, clinically apparent brain injury; DKA, diabetic ketoacidosis.